251
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)

ORCID Icon, , , &
Pages 2652-2658 | Received 24 Apr 2020, Accepted 25 May 2020, Published online: 19 Jun 2020

References

  • Axelrod PI, Lorber B, Vonderheid EC. Infections complicating mycosis fungoides and Sezary syndrome. JAMA. 1992;267(10):1354–1358.
  • Nguyen V, Huggins RH, Lertsburapa T, et al. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization. J Am Acad Dermatol. 2008;59(6):949–952.
  • Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008;159(1):105–112.
  • Willerslev-Olsen A, Krejsgaard T, Lindahl LM, et al. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood. 2016;127(10):1287–1296.
  • Blumel E, Willerslev-Olsen A, Gluud M, et al. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma. Oncoimmunology. 2019;8(11):e1641387.
  • Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, et al. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma. Blood. 2019;134(13):1072–1083.
  • Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115(4):798–812.
  • Wysocka M, Zaki MH, French LE, et al. Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines . Blood. 2002;100(9):3287–3294.
  • Papadavid E, Economidou J, Psarra A, et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome. Br J Dermatol. 2003;148(4):709–718.
  • Whittaker S, Hoppe R, Prince HM. How I treat mycosis fungoides and Sézary syndrome. Blood. 2016;127(25):3142–3153.
  • Kim YH, Bagot M, Pinter-Brown L, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(9):1192–1204.
  • Blaizot R, Ouattara E, Fauconneau A, et al. Infectious events and associated risk factors in mycosis fungoides/Sezary syndrome: a retrospective cohort study. Br J Dermatol. 2018;179(6):1322–1328.
  • Posner LE, Fossieck BE, Jr., Eddy JL, et al. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med. 1981;71(2):210–216.
  • Balagula Y, Dusza SW, Zampella J, et al. Early-onset mycosis fungoides among African American women: a single-institution study. J Am Acad Dermatol. 2014;71(3):597–598.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.